ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 179 filers reported holding ARGENX SE in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $445,908 | +19.1% | 907 | -5.6% | 0.02% | +25.0% |
| Q2 2023 | $374,531 | -12.2% | 961 | -16.1% | 0.02% | -23.1% |
| Q1 2023 | $426,604 | +6.5% | 1,145 | +8.3% | 0.03% | 0.0% |
| Q4 2022 | $400,423 | -44.6% | 1,057 | -48.4% | 0.03% | -50.0% |
| Q3 2022 | $723,000 | -16.2% | 2,049 | -10.1% | 0.05% | -5.5% |
| Q2 2022 | $863,000 | +3.6% | 2,279 | -13.7% | 0.06% | +57.1% |
| Q1 2022 | $833,000 | +85.1% | 2,641 | +105.4% | 0.04% | +133.3% |
| Q4 2021 | $450,000 | +43.3% | 1,286 | +23.5% | 0.02% | +36.4% |
| Q3 2021 | $314,000 | +4.7% | 1,041 | +4.4% | 0.01% | +10.0% |
| Q2 2021 | $300,000 | +12.4% | 997 | +2.7% | 0.01% | 0.0% |
| Q1 2021 | $267,000 | -2.9% | 971 | +3.7% | 0.01% | -16.7% |
| Q4 2020 | $275,000 | – | 936 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |